Welcome to LookChem.com Sign In|Join Free

CAS

  • or

82202-32-2

Post Buying Request

82202-32-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

82202-32-2 Usage

Description

2-Amino-5-bromo-4-t-butylthiazole is a chemical compound with the molecular formula C8H10BrN2S. It is a brominated thiazole derivative with a t-butyl group. 2-AMino-5-broMo-4-t-butylthiazole is characterized by its unique chemical structure and properties, making it a valuable building block in various applications.

Uses

Used in Organic Synthesis:
2-Amino-5-bromo-4-t-butylthiazole is used as a building block in organic synthesis for the creation of various pharmaceuticals and bioactive compounds. Its unique chemical structure allows for the development of new and innovative molecules with potential therapeutic and industrial applications.
Used in Pharmaceutical Research:
In pharmaceutical research, 2-Amino-5-bromo-4-t-butylthiazole is utilized as a key component in the design and synthesis of new drugs. Its interesting chemical properties make it a promising candidate for the development of novel therapeutic agents.
Used in Agrochemical Development:
2-Amino-5-bromo-4-t-butylthiazole may also have potential applications in the development of new agrochemicals. Its unique chemical properties could contribute to the creation of innovative products for agricultural use.
Safety Precautions:
It is important to handle 2-Amino-5-bromo-4-t-butylthiazole with care, as it may pose health and environmental risks if not used properly. Proper safety measures should be taken to minimize any potential hazards associated with this chemical compound.
Overall, 2-Amino-5-bromo-4-t-butylthiazole is a valuable chemical for the advancement of scientific research and the development of new products in various industries, including pharmaceuticals and agrochemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 82202-32-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,2,0 and 2 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 82202-32:
(7*8)+(6*2)+(5*2)+(4*0)+(3*2)+(2*3)+(1*2)=92
92 % 10 = 2
So 82202-32-2 is a valid CAS Registry Number.

82202-32-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-bromo-4-tert-butyl-1,3-thiazol-2-amine

1.2 Other means of identification

Product number -
Other names 2-Amino-5-bromo-4-t-butylthiazole

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:82202-32-2 SDS

82202-32-2Relevant articles and documents

NF-KB ACTIVATION INHIBITORS

-

Page/Page column 110, (2008/06/13)

A medicament having inhibitory activity against NF-κB activation which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein A represents hydrogen atom or acetyl group, E represents a 2,5-di-substituted or a 3,5-di-substituted phenyl group, or a monocyclic or a fused polycyclic heteroaryl group which may be substituted, provided that the compound wherein said heteroaryl group is 1○ a fused polycyclic heteroaryl group wherein the ring which binds directly to ―CONH― group in the formula (I) is a benzene ring, 2○ unsubstituted thiazol-2-yl group, or 3○ unsubstituted benzothiazol-2-yl group is excluded, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula ―O―A wherein A has the same meaning as that defined above and the group represented by formula -CONH-E wherein E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula ―O―A wherein A has the same meaning as that defined above and the group represented by formula ― CONH―E wherein E has the same meaning as that defined above.

REMEDIES FOR NEURODEGENERATIVE DISEASES

-

Page/Page column 109, (2010/02/12)

A medicament for preventive and/or therapeutic treatment of neurodegenerative diseases such as Alzheimer's disease or the like which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein A represents hydrogen atom or acetyl group, E represents a 2,5-di-substituted or a 3,5-di-substituted phenyl group, or a monocyclic or a fused polycyclic heteroaryl group which may be substituted, provided that the compound wherein said heteroaryl group is 1○ a fused polycyclic heteroaryl group wherein the ring which binds directly to -CONH- group in the formula (I) is a benzene ring, 2○ unsubstituted thiazol-2-yl group, or 3○ unsubstituted benzothiazol-2-yl group is excluded, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -CONH-E wherein E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -CONH-E wherein E has the same meaning as that defined above.

IMMUNITY-RELATED PROTEIN KINASE INHIBITORS

-

Page/Page column 153, (2010/02/10)

[From equivalent EP1510210A1] A medicament having an inhibitory activity against IKK-Aβ and/or MEKK-1 or other protein kinases structurally similar thereto, which comprises as an active ingredient a substance selected from the group consisting of a compound represented by the following general formula (I) and a pharmacologically acceptable salt thereof, and a hydrate thereof and a solvate thereof: wherein X represents a connecting group whose number of atoms in the main chain is 2 to 5 (said connecting group may be substituted), A represents hydrogen atom or acetyl group, E represents an aryl group which may be substituted or a hetero aryl group which may be substituted, ring Z represents an arene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above, or a heteroarene which may have one or more substituents in addition to the group represented by formula -O-A wherein A has the same meaning as that defined above and the group represented by formula -X-E wherein each of X and E has the same meaning as that defined above.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 82202-32-2